News | March 18, 2023
Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The inspection concluded with no observations
Subscribe To Our Newsletter & Stay Updated
